Literature DB >> 8853221

Behavioural and anticonvulsant effects of Ca2+ channel toxins in DBA/2 mice.

H C Jackson1, M A Scheideler.   

Abstract

This study investigated the behavioural and anticonvulsant effects of voltage-sensitive calcium channel blockers in DBA/2 mice. Omega-Conotoxin MVIIC (0.1, 0.3 micrograms ICV/mouse) and omega-agatoxin IVA (0.1, 0.3, 1 micrograms ICV), which act predominantly at P- and/or Q-type calcium channels, prevented clonic and tonic sound-induced seizures in this animal model of reflex epilepsy (ED50 values with 95% confidence limits for protection against clonic sound-induced seizures were 0.09 (0.04-0.36) micrograms ICV and 0.09 (0.05-0.15) micrograms ICV respectively and against tonic seizures 0.07 (0.03-0.16) micrograms ICV and 0.08 (0.04-0.13) micrograms ICV, respectively). The N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA were also tested in this model. Omega-Conotoxin GVIA was anticonvulsant in DBA/2 mice, but only at high doses (3 micrograms ICV prevented tonic seizures in 60% of the animals; 10 micrograms ICV prevented clonic seizures in 60% and tonic seizures in 90% of the animals), whereas omega-conotoxin MVIIA did not inhibit sound-induced seizures in doses up to 10 micrograms ICV. Both omega-conotoxin GVIA and omega-conotoxin MVIIA induced an intense shaking syndrome in doses as low as 0.1 microgram ICV, whereas omega-conotoxin MVIIC and omega-agatoxin IVA did not produce shaking at any of the doses examined. Finally, omega-conotoxin GI (0.01-1 microgram ICV) and alpha-conotoxin SI (0.3-30 micrograms ICV), which both act at acetylcholine nicotinic receptors, were not anticonvulsant and did not induce shaking in DBA/2 mice. These results confirm that blockers of N- and P-/Q-type calcium channels produce different behavioural responses in animals. The anticonvulsant effects of omega-conotoxin MVIIC and omega-agatoxin IVA in DBA/2 mice are consistent with reports that P- and/or Q-type calcium channel blockers inhibit the release of excitatory amino acids and are worthy of further exploration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853221     DOI: 10.1007/bf02246415

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  Calcium channels coupled to glutamate release identified by omega-Aga-IVA.

Authors:  T J Turner; M E Adams; K Dunlap
Journal:  Science       Date:  1992-10-09       Impact factor: 47.728

2.  A new Conus peptide ligand for mammalian presynaptic Ca2+ channels.

Authors:  D R Hillyard; V D Monje; I M Mintz; B P Bean; L Nadasdi; J Ramachandran; G Miljanich; A Azimi-Zoonooz; J M McIntosh; L J Cruz
Journal:  Neuron       Date:  1992-07       Impact factor: 17.173

3.  P-type calcium channels blocked by the spider toxin omega-Aga-IVA.

Authors:  I M Mintz; V J Venema; K M Swiderek; T D Lee; B P Bean; M E Adams
Journal:  Nature       Date:  1992-02-27       Impact factor: 49.962

4.  Convulsant and anticonvulsant actions in DBA/2 mice of compounds blocking the reuptake of GABA.

Authors:  R W Horton; J F Collins; G M Anlezark; B S Meldrum
Journal:  Eur J Pharmacol       Date:  1979-10-26       Impact factor: 4.432

5.  Peptide toxins from Conus geographus venom.

Authors:  W R Gray; A Luque; B M Olivera; J Barrett; L J Cruz
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

6.  Peptide neurotoxins from fish-hunting cone snails.

Authors:  B M Olivera; W R Gray; R Zeikus; J M McIntosh; J Varga; J Rivier; V de Santos; L J Cruz
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

7.  Anticonvulsant effects of some calcium entry blockers in DBA/2 mice.

Authors:  G B De Sarro; B S Meldrum; G Nisticó
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

8.  Effects of diverse omega-conopeptides on the in vivo release of glutamic and gamma-aminobutyric acids.

Authors:  R Newcomb; A Palma
Journal:  Brain Res       Date:  1994-02-28       Impact factor: 3.252

9.  Effect of various calcium channel blockers on three different models of limbic seizures in rats.

Authors:  A Vezzani; H Q Wu; M A Stasi; P Angelico; R Samanin
Journal:  Neuropharmacology       Date:  1988-05       Impact factor: 5.250

10.  Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.

Authors:  S Gaur; R Newcomb; B Rivnay; J R Bell; D Yamashiro; J Ramachandran; G P Miljanich
Journal:  Neuropharmacology       Date:  1994-10       Impact factor: 5.250

View more
  9 in total

1.  Pro- and Anticonvulsant Effects of the Ant Dinoponera quadriceps (Kempf) Venom in Mice.

Authors:  D A M F Nôga; F C Cagni; J R Santos; D Silva; D L O Azevedo; A Araújo; R H Silva; A M Ribeiro
Journal:  Neotrop Entomol       Date:  2015-06-05       Impact factor: 1.434

2.  Prolonged attenuation of amygdala-kindled seizure measures in rats by convection-enhanced delivery of the N-type calcium channel antagonists omega-conotoxin GVIA and omega-conotoxin MVIIA.

Authors:  Maciej Gasior; Natalie A White; Michael A Rogawski
Journal:  J Pharmacol Exp Ther       Date:  2007-08-23       Impact factor: 4.030

3.  Glucokinase activity in the arcuate nucleus regulates glucose intake.

Authors:  Syed Hussain; Errol Richardson; Yue Ma; Christopher Holton; Ivan De Backer; Niki Buckley; Waljit Dhillo; Gavin Bewick; Shuai Zhang; David Carling; Steve Bloom; James Gardiner
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

Review 4.  Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit.

Authors:  Steven C Schachter; John Guttag; Steven J Schiff; Donald L Schomer
Journal:  Epilepsy Behav       Date:  2009-09       Impact factor: 2.937

Review 5.  Convection-enhanced delivery in the treatment of epilepsy.

Authors:  Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

6.  Mass spectrometric identification and denovo sequencing of novel conotoxins from vermivorous cone snail (Conus inscriptus), and preliminary screening of its venom for biological activities in vitro and in vivo.

Authors:  Ruchi P Jain; Benjamin Franklin Jayaseelan; Carlton Ranjith Wilson Alphonse; Ahmed Hossam Mahmoud; Osama B Mohammed; Bandar Mohsen Ahmed Almunqedhi; Rajesh Rajaian Pushpabai
Journal:  Saudi J Biol Sci       Date:  2020-12-24       Impact factor: 4.219

7.  Study on the Antinociceptive Effects of Herba Epimedium in Mice.

Authors:  Jiang-Hong Sun; Xin-Jie Ruan; Li-Na Wang; Shuang Liang; Xin-Ping Li
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-11       Impact factor: 2.629

8.  Anticonvulsant Effects of Fractions Isolated from Dinoponera quadriceps (Kempt) Ant Venom (Formicidae: Ponerinae).

Authors:  Diana Aline Morais Ferreira Nôga; Luiz Eduardo Mateus Brandão; Fernanda Carvalho Cagni; Delano Silva; Dina Lilia Oliveira de Azevedo; Arrilton Araújo; Wagner Ferreira Dos Santos; Antonio Miranda; Regina Helena da Silva; Alessandra Mussi Ribeiro
Journal:  Toxins (Basel)       Date:  2016-12-23       Impact factor: 4.546

9.  Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders.

Authors:  Victoria Monge-Fuentes; Flávia Maria Medeiros Gomes; Gabriel Avohay Alves Campos; Juliana de Castro Silva; Andréia Mayer Biolchi; Lilian Carneiro Dos Anjos; Jacqueline Coimbra Gonçalves; Kamila Soares Lopes; Márcia Renata Mortari
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.